Cell Therapeutics Inc. (CTIC) Widens Q2 Loss to 28c/Share
Tweet Send to a FriendGet Alerts CTIC Hot Sheet
Price: $1.24 -6.77%
EPS Growth %: -122.2%
Financial Fact:
Foreign exchange gain (loss): -751K
Today's EPS Names:
CEDU, CHC, CIDM, More
EPS Growth %: -122.2%
Financial Fact:
Foreign exchange gain (loss): -751K
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade CTIC Now!
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q2 EPS of ($0.28), versus ($0.14) reported last year.
For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment
- John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
